Owens & Minor Inc/va/ 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Accendra Health's Q2 2026 results show a significant decline in net revenue and an increase in net loss, impacted by contract terminations and debt restructuring.
Accendra Health's Q1 2026 results show a revenue decline driven by a major contract termination, alongside progress in its balance sheet optimization transaction.
Owens & Minor posted a significant net loss in Q3 2025, driven by one-time charges from the Products & Healthcare Services segment sale and the termination of the Rotech acquisition, while also facing a major commercial payor contract loss.
Owens & Minor, Inc. reported a significant net loss in Q2 2025, primarily driven by the classification of its P&HS segment as discontinued operations and the termination of the Rotech acquisition.
10-Q: Owens & Minor Reports Q1 2025 Results, Impacted by Acquisition Costs and Strategic Initiatives
Owens & Minor's Q1 2025 results reflect a net loss, influenced by acquisition-related charges and strategic realignment, alongside revenue growth in the Patient Direct segment.
Owens & Minor's Q3 2024 results show a net loss, impacted by legal settlements and tax adjustments, but also reveal revenue growth and cost-saving initiatives.
Owens & Minor's second quarter results show a net loss, impacted by a tax adjustment, but also reveal revenue growth and cost savings initiatives.
Owens & Minor's first quarter of 2024 saw a slight improvement in net loss per share, driven by revenue growth and cost savings, but offset by increased restructuring charges.